CoChat

Senescent-like Blood Lymphocytes and Disease Progression in Amyotrophic Lateral Sclerosis

Open access
Yildiz, Ozlem, Schroth, Johannes, Tree, Timothy, Turner, Martin R., Shaw, Pamela J., Henson, Sian M., Malaspina, Andrea · 2023 · Neurology Neuroimmunology & Neuroinflammation

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Abstract

Background and Objectives Aging is known to exacerbate neuroinflammation, and in the neurodegenerative disorder amyotrophic lateral sclerosis (ALS), an older age is associated with a worse prognosis. We have previously shown the activation of cell senescence pathways in the proteome of peripheral blood mononuclear cells and the increase of proinflammatory cytokines in blood from individuals living with ALS. In this single-center, retrospective study, we investigated the expression of senescent-like blood mononuclear cells in ALS. Methods We first applied multidimensional cytometry by time-of-flight (CyTOF) to study the senescent immunophenotype of blood mononuclear cells from 21 patients with ALS and 10 healthy controls (HCs). We then used targeted flow cytometry (FC) to investigate frequencies of senescent blood lymphocytes in 40 patients with ALS and 20 HCs. Longitudinal analysis included 2 additional time points in 17 patients with ALS. Frequencies of senescent-like lymphocytes were analyzed in relation to survival. Results Unsupervised clustering of CyTOF data showed higher frequencies of senescent CD4+CD27−CD57+ T cells in patients with ALS compared with those in HCs (p = 0.0017, false discovery (FDR)-adjusted p = 0.029). Moderate to strong negative correlations were identified between CD4 T central memory–cell frequencies and survival (R = −061, p = 0.01; FDR-adjusted p < 0.1) and between CD95 CD8 cells and ALS functional rating scale revised at baseline (R = −0.72, p = 0.001; FDR-adjusted p < 0.1).Targeted FC analysis showed higher memory T regulatory cells (p = 0.0052) and memory CD8+ T cell (M-Tc; p = 0.0006) in bulbar ALS (A-B) compared with those in limb ALS (A-L), while late memory B cells (LM-B) were also elevated in A-B and fast-progressing ALS (p = 0.0059). Higher M-Tc levels separated A-B from A-L (AUC: 0.887; p < 0.0001). A linear regression model with prespecified clinical independent variables and neurofilament light chain plasma concentration showed that higher frequencies of LM-B predicted a shorter survival (hazard ratio: 1.094, CI: 1.026–1.167; p = 0.006). Discussion Our data suggest that a systemic elevation of senescent and late memory T and B lymphocytes is a feature of faster progressing ALS and of ALS individuals with bulbar involvement. Lymphocyte senescence and their memory state may be central to the immune dysregulation known to drive disease progression in ALS and a target for biomarkers and therapeutics discovery.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/nxi.0000000000200042

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Unsupervised Clustering Analysis Reveals a Senescent Population of CD4 T Cells in Patients With ALS (A) Heatmap showing phenograph clustering of 22 lineage markers identifying 19 clusters with a frequency above the 1% threshold, which were grouped into 17 meta-clusters according to their lineage marker expression. Clusters with a frequency of less than 1% were excluded and grouped into the “Excluded” cluster (NA, 6th row from the top). Cluster frequencies are shown together with their assigned cell type. (B) t-distributed stochastic neighbor embedding (tSNE) of 100,000 down sampled cells for patients with ALS and HCs (50,000 per HC and ALS group), colored by phenograph-determined cell types. (C) Frequency of CD4 senescent T cells (CD4 T SEN) as a percentage of live cells identified by unsupervised phenograph clustering in the HC and ALS groups. p values determined through quasi-likelihood negative binomial generalized linear models. ALS = amyotrophic lateral sclerosis; CD4 T SEN = CD4 cells expressing CD57; HC = healthy control.
Figure 1 Unsupervised Clustering Analysis Reveals a Senescent Population of CD4 T Cells in Patients With ALS (A) Heatmap showing phenograph clustering of 22 lineage markers identifying 19 clusters with a frequency above the 1% threshold, which were grouped into 17 meta-clusters according to their lineage marker expression. Clusters with a frequency of less than 1% were excluded and grouped into the “Excluded” cluster (NA, 6th row from the top). Cluster frequencies are shown together with their assigned cell type. (B) t-distributed stochastic neighbor embedding (tSNE) of 100,000 down sampled cells for patients with ALS and HCs (50,000 per HC and ALS group), colored by phenograph-determined cell types. (C) Frequency of CD4 senescent T cells (CD4 T SEN) as a percentage of live cells identified by unsupervised phenograph clustering in the HC and ALS groups. p values determined through quasi-likelihood negative binomial generalized linear models. ALS = amyotrophic lateral sclerosis; CD4 T SEN = CD4 cells expressing CD57; HC = healthy control.CC BY · PubMed Central
Figure 2 CyTOF Analysis: Association Between Blood Mononuclear Cell Frequencies and Clinical Parameters FDR-adjusted partial correlation analysis correcting for batch effect showed moderate to strong negative correlations between CD4 central memory (CM) cell frequencies and survival and between CD95 (Fas) CD8 cells and ALSFRSR at baseline. ALSFRS-R = amyotrophic lateral sclerosis functional rating scale revised; CyTOF = cytometry by time-of-flight.
Figure 2 CyTOF Analysis: Association Between Blood Mononuclear Cell Frequencies and Clinical Parameters FDR-adjusted partial correlation analysis correcting for batch effect showed moderate to strong negative correlations between CD4 central memory (CM) cell frequencies and survival and between CD95 (Fas) CD8 cells and ALSFRSR at baseline. ALSFRS-R = amyotrophic lateral sclerosis functional rating scale revised; CyTOF = cytometry by time-of-flight.CC BY · PubMed Central
Figure 3 FC Gating Strategy Schematic representation of gating strategy for T cells (A), B cells (B) and T-cell senescence panels (shown for CD8+ T cells) (C) used in the FC experiments. FC = flow cytometry.
Figure 3 FC Gating Strategy Schematic representation of gating strategy for T cells (A), B cells (B) and T-cell senescence panels (shown for CD8+ T cells) (C) used in the FC experiments. FC = flow cytometry.CC BY · PubMed Central
Figure 4 Analysis of T-Cell Subset Frequencies and Association With Site of Onset and Disease Progression in Individuals With ALS (A) FoxP3+ Tregs expression is significantly higher in blood from patients with ALS compared with that in HCs. (B) M-Tregs are elevated in ALS and A-B. (C) M-Tc frequencies are significantly upregulated in A-B compared with that in A-L. (D) ROC analysis testing M-Tc ability to separate A-B from A-L. A-B = bulbar ALS; A-L = limb-onset ALS; ALS = amyotrophic lateral sclerosis; HCs = healthy controls; M-Tc = memory CD8+ T cells; M-Tregs = memory T regulatory cells; ROC = receiver operating characteristic.
Figure 4 Analysis of T-Cell Subset Frequencies and Association With Site of Onset and Disease Progression in Individuals With ALS (A) FoxP3+ Tregs expression is significantly higher in blood from patients with ALS compared with that in HCs. (B) M-Tregs are elevated in ALS and A-B. (C) M-Tc frequencies are significantly upregulated in A-B compared with that in A-L. (D) ROC analysis testing M-Tc ability to separate A-B from A-L. A-B = bulbar ALS; A-L = limb-onset ALS; ALS = amyotrophic lateral sclerosis; HCs = healthy controls; M-Tc = memory CD8+ T cells; M-Tregs = memory T regulatory cells; ROC = receiver operating characteristic.CC BY · PubMed Central
Figure 5 Analysis of B-Cell Subset Frequencies and Their Correlation With Disease Progression in ALS (A) Blood frequencies of LM-B are increased in A-F. The blood expression of LM-B separates ALS from HCs and A-S (ROC analyses). (B) Blood frequencies of M-B are higher in HCs compared with those in ALS. A-F = faster progressing ALS; ALS = amyotrophic lateral sclerosis; A-S = slow progressive ALS; HCs = healthy controls; LM-B = late memory B cells; M-B = memory B cells; N-B = naive B cells; ROC = receiver operating characteristic.
Figure 5 Analysis of B-Cell Subset Frequencies and Their Correlation With Disease Progression in ALS (A) Blood frequencies of LM-B are increased in A-F. The blood expression of LM-B separates ALS from HCs and A-S (ROC analyses). (B) Blood frequencies of M-B are higher in HCs compared with those in ALS. A-F = faster progressing ALS; ALS = amyotrophic lateral sclerosis; A-S = slow progressive ALS; HCs = healthy controls; LM-B = late memory B cells; M-B = memory B cells; N-B = naive B cells; ROC = receiver operating characteristic.CC BY · PubMed Central
Figure 6 Changes of Lymphocyte Frequencies in Longitudinal Blood Samples Box plot representation of ANOVA for repeated measures analysis (mixed model with missing values at random) of the changes from V1 to V3 showing a significant increase over time of CD3 (p = 0.0259) and the relative stability of CD4 and CD8. All remaining T-cell and B-cell subgroups under investigation, including those expressing markers of cell senescence, show variable patterns of expression but no significant changes across time points.
Figure 6 Changes of Lymphocyte Frequencies in Longitudinal Blood Samples Box plot representation of ANOVA for repeated measures analysis (mixed model with missing values at random) of the changes from V1 to V3 showing a significant increase over time of CD3 (p = 0.0259) and the relative stability of CD4 and CD8. All remaining T-cell and B-cell subgroups under investigation, including those expressing markers of cell senescence, show variable patterns of expression but no significant changes across time points.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Research works printed but not linked: 1

  1. 10.1093/hmg/ddx247 · DOI · Paper page

Cited by

See all 40

Metadata

Authors
Yildiz, O., Schroth, J., Tree, T., Turner, M. R., Shaw, P. J., Henson, S. M., & Malaspina, A.
Affiliations
  • From the Neuroscience and Trauma Centre (O.Y., A.M.), Blizard Institute, Barts and The London School of Medicine &amp; Dentistry, Queen Mary University of London; Queen Square Motor Neuron Disease Centre (A.M.), Neuromuscular Department, Institute of Neurology, University College London; Translational Medicine and Therapeutics (J.S., S.M.H.), William Harvey Research Institute, Barts and the London, Queen Mary University of London; Department of Immunobiology (T.T.), School of Immunology &amp;...
  • Queen Mary University of London (GB)
Corresponding author
Malaspina, Andrea
Venue
Neurology Neuroimmunology & Neuroinflammation
Published
2023-01
Volume
10
Issue
1
ISSN
2332-7812 (ISSN-L)
OpenAlex
W4308135426
Cited by
39
References
49
Citations by year
2026: 11 · 2025: 9 · 2024: 14 · 2023: 5
FWCI
3.69
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Neurology Neuroimmunology & Neuroinflammation (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • Queen Mary Research Online (Queen Mary University of London) (submittedVersion, cc-by)
Funders
  • Barts Charity (MRC0218, G-001960)
  • National Institute for Health and Care Research (NF-SI-0617-10077, BRC‐1215‐20017)
  • Motor Neurone Disease Association (TURNER/OCT18/989-797, TURNER/OCT15/972-797)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
Keywords
amyotrophic lateral sclerosis, cellular senescence, blood mononuclear cells, memory CD8+ T cells, neuroinflammation, disease progression, survival, neurofilament light chain, prognostic factors, Fas
MeSH terms
Amyotrophic Lateral Sclerosis, Humans, Leukocytes, Mononuclear, Retrospective Studies, CD4-Positive T-Lymphocytes, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Senescent-like Blood Lymphocytes and Disease Progression in Amyotrophic Lateral Sclerosis. https://app.cochat.ai/papers/10.1212/nxi.0000000000200042
The paper
Yildiz, O., Schroth, J., Tree, T., Turner, M. R., Shaw, P. J., Henson, S. M., & Malaspina, A. (2023). Senescent-like Blood Lymphocytes and Disease Progression in Amyotrophic Lateral Sclerosis. Neurology Neuroimmunology & Neuroinflammation. https://doi.org/10.1212/nxi.0000000000200042

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.